Neko Health has secured a significant investment of $700 million, expanding its presence in the healthcare industry with a focus on preventive screening services. The funding came from Lightspeed Venture Partners and O.G. Venture Partners, both leading venture capital firms specializing in technology and healthcare investments.
The new investment will enable Neko Health to further refine its AI body scan service, which combines medical imaging, blood tests, proprietary sensors, and clinician review. This technology has the potential to revolutionize the way healthcare is delivered by providing early detection of diseases and conditions that may have gone undetected or untreated otherwise.
With this new funding, Neko Health plans to expand its clinic network in the United States, including a presence in New York, which marks the company's first expansion into the country. The investment represents a significant milestone for the company, as it continues to build upon its innovative approach to healthcare delivery and explore new opportunities for growth and expansion.